Skip Nav Destination
1-20 of 42
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
First-in-Human Study of Abbv-621, a TRAIL Receptor Agonist Fusion Protein, in Patients (Pts) with Relapsed/Refractory (RR) Acute Myeloid Leukemia (AML) and Diffuse Large B-Cell Lymphoma (DLBCL)
Maja J.A. de Jonge, MD, Benedito A. Carneiro, MD, Lot Devriese, MD PhD, Toshihiko Doi, MD PhD, Sudhir Penugonda, MD MPH, Adam M. Petrich, MD, Silpa Nuthalapati, PhD, Monica Motwani, PhD, Dimple A. Modi, PhD, Yu-Wei Chang, PhD, Emiliano Calvo, MD PhD, Victor Moreno, MD PhD
Blood (2019) 134 (Supplement_1): 3924.
Low vs high hemoglobin trigger for transfusion in vascular surgery: a randomized clinical feasibility trial
Clinical Trials & Observations
Anders Møller, Henning B. Nielsen, Jørn Wetterslev, Ole B. Pedersen, Dorthe Hellemann, Per Winkel, Klaus V. Marcussen, Benedicte G. U. Ramsing, Anette Mortensen, Janus C. Jakobsen, Saeid Shahidi
Blood (2019) 133 (25): 2639–2650.
Includes: Supplemental data
Comparison between Automated Erythrocytopharesis (AECP) and Manual Exchange Transfusion (M-Ex)) in Reducing Hb-S and in Recovery of Acute Chest Syndrome and Other Acute Presentations of Sickle Cell Disease Patients
Said Yousuf Ahmed, MD, Sameh M. Saleh, MD, Mohamed Shefan Hameed, MD, Ahmed M. Ragheb, MD, Telal M. Abbas, MD, AbdelMunim Fadel, Siddiq Hassan, MD, Hussein S. Baden, MBBS, FRCP, FRCPath, Khaled I Tayeb, MD, Nasir Bakshi, MD, Ghaleb El Yamany, MBBS, FRCP, FRCPath, Sultan Bejad Alotaibi
Blood (2018) 132 (Supplement 1): 4928.
Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Cognition in children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b paediatric cohort)
April E Slee, Jamie M Kawadler, PhD, Melanie Koelbel, MSc, Hanne Stotesbury, MSc, David C Rees, MD, Maria Pelidis, MD, Jo Howard, MBBCh, Swee Lay Thein, DSc,FRCP,FRCPath,MBBS,MRCPath,MRCP, Simon Skene, PhD, Sahota Sati, BSc, Carol Nwosu, BSc, Maureen Gwam, BSc, Dawn Saunders, MD, Johanna C Gavlak, PhD, Gupta Atul, MD, Simrat Sarkaria, Christina Liossi, PhD, Fenella J Kirkham, MD, Baba Inusa, MD MRCP
Blood (2017) 130 (Supplement 1): 3556.
Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Pain and Quality of Life in Children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b pediatric cohort)
Baba Inusa, MD MRCP, Jo Howard, MBBCh, Subarna Chakravorty, MBBS, PhD FRCPath, MRCP, Maria Pelidis, MD, Swee Lay Thein, DSc,FRCP,FRCPath,MBBS,MRCPath,MRCP, Fenella J Kirkham, MD
Blood (2017) 130 (Supplement 1): 3537.
Bryan Christopher Hambley, MDMPH, Rania Abdul Rahman, MD, Mary Ann O'Riordan, PhD, Nathan Langer, MD, Seth Rotz, MD, Aaron Smith, Robert Schilz, DO/PhD, Mahazarin Ginwalla, MD, Jane A. Little, MD
Blood (2016) 128 (22): 3659.
Oxidative Stress in Blood Cells Associated with Obstructive Sleep Apnea Contributes to Absence of Hypoxia-Induced Polycythemia
Jihyun Song, PhD, Krishna M Sundar, MD, Radhika Gangaraju, MD, Subhashree Sundar, Perumal Thiagarajan, MD, Josef T. Prchal, MD
Blood (2016) 128 (22): 2442.
Safe Deep Sedation with Midazolam and Propofol for Cerebral MRI in Young Children with Sickle Cell Disease Is Safe: A Single Center Experience in Belgium
Cécile Callewaert, MD, Laurence Dedeken, MD, Françoise De Groote, MD, Laurence Rozen, Phu-Quoc Lê, MD, Sophie Huybrechts, MD, Safiatou Diallo, MD, Christine Devalck, MD, Catherine Heijmans, MD, Andrée De Ville, MD, Alina Ferster, MD
Blood (2016) 128 (22): 1324.
Prospective Implementation of Multi-Disciplinary Obstetric Team Decreases the Mortality Rate of Pregnant Women with Sickle Cell Disease in Ghana
Eugenia Vicky Naa Kwarley Asare, MBChB, BSc, Yvonne Adomakoh, MBBS, Edeghonghon Olayemi, MBBS, MSc, FWACP, Enoch Mensah, HND, Harriet Ghansah, BSc, Yvonnne Osei- Bonsu, Dip(PH), Selina Crabbe, Dip(PH), Latif Musah, BSc, Charles Hayfron- Benjamin, MBChB, Theodore Boafor, MBChB, Brittany Covert, MPH, CCRP, Adetola A. Kassim, MD MS, Andra H. James, MD MPH, Michael DeBaun, MD, Samuel Antwi Oppong, MBChB
Blood (2016) 128 (22): 1017.
A Pilot Study of Sleep Disordered Breathing (SDB) and Nocturnal Hypoxemia in Young Adults with Sickle Cell Disease
Susan P. Perrine, MD, Oluwakemi Owoyemi, MD MPH, Elizabeth S Klings, MD, Mehdi Nouraie, MD PhD, Angela Rock, Patricia A. Oneal, Thomas Mellman, MD, Tessema Berihun, Peter L. Whitesell, MD, Joseph Lavela, Robert E. Taylor, MD PhD
Blood (2015) 126 (23): 3414.
Blood (2015) 126 (23): 3348.
Massive Pulmonary and Coronary Artery Thromboembolism in the Setting of Undetected Patent Foramen Ovale
Blood (2015) 126 (23): 4718.
Analysis of Hemodynamic Changes and Bold Signals of Sickle Cell Disease Patients during Desaturation
Julie Coloigner †, PhD, Chau Vu †, Matt Borzage, PhD, Adam M Bush, MS, Natasha Lepore, PhD, Thomas D. Coates, MD, John C Wood, MD PhD
Blood (2015) 126 (23): 3384.
HIF-Mediated Changes in Erythropoiesis and Gene Expression in Chronic Intermittent Hypoxia Due to Obstructive Sleep Apnea
Blood (2014) 124 (21): 1334.
Jane A. Little, MD, Seth Rotz, MD, Ceonne Kim, BS, MaryAnn O'Riordan, PhD, Nathan Langer, MD, Colleen Lance, MD
Blood (2014) 124 (21): 1384.
Desaturation Is Related to the Presence of Dense Red Blood Cells in Sickle Cell Patients and Is Reversed By Hydroxyurea
Gaetana Di Liberto, Laurent Kiger, Michael Marden, Laurent Boyer, Marc Conti, Anoosha Habibi, Marie Georgine Rakotoson, Sanam Khorgami, Benoit Vingert, Bernard Maitre, Frédéric Galacteros, France Noizat-Pirenne, Pablo Bartolucci
Blood (2014) 124 (21): 2713.
Blood (2013) 122 (21): 2210.
Samit Ghosh, PhD, Olufolake Adisa, MD, Prasanthi Chappa, Fang Tan, PhD, Kesmic A Jackson, PhD, David R. Archer, PhD, Solomon F Ofori-Acquah, PhD
Blood (2013) 122 (21): 727.
Delayed Recovery of Venous Oxygen Saturation and Lactate in SCT Subjects Following Exercise and Their Association with Red Cell Oxidative Stress
John C Wood, MD, Ph.D, Hongqiao Zhang, PhD, Adam M Bush, BS, Roberta Miyeko Kato, MD, Honglei Liu, PhD, Ani Dongelyan, BA, Anne Nord, RN, BSN, CCRP, Thomas D. Coates, MD, Henry J Forman, PhD
Blood (2012) 120 (21): 3244.
A Phase 1, First-in-Man, Dose-Response Study of Aes-103 (5-HMF), an Anti-Sickling, Allosteric Modifier of Hemoglobin Oxygen Affinity in Healthy Norman Volunteers
Warren Stern, Ph.D., David Mathews, M.D., John McKew, Ph.D., Xiqgiang Shen, Ph.D., Gregory J. Kato, M.D.
Blood (2012) 120 (21): 3210.